▶ 調査レポート

ドライアイ疾患治療の世界市場2020-2030:製品別(人工涙液、抗炎症剤[シクロスポリン、コルチコステロイド、その他]、涙点プラグ、分泌促進薬、その他)、疾患別、流通チャンネル別

• 英文タイトル:Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Transparency Market Researchが調査・発行した産業分析レポートです。ドライアイ疾患治療の世界市場2020-2030:製品別(人工涙液、抗炎症剤[シクロスポリン、コルチコステロイド、その他]、涙点プラグ、分泌促進薬、その他)、疾患別、流通チャンネル別 / Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / TMR2008083資料のイメージです。• レポートコード:TMR2008083
• 出版社/出版日:Transparency Market Research / 2020年7月30日
• レポート形態:英文、PDF、214ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥620,065 (USD5,795)▷ お問い合わせ
  Multi User¥941,065 (USD8,795)▷ お問い合わせ
  Corporate License¥1,262,065 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートではドライアイ疾患治療の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(人工涙、抗炎症薬、涙点プラグ、分泌促進物質、その他)分析、疾患別(蒸発性ドライアイ症候群、水性ドライアイ症候群)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、以下の構成でご提供いたします。
・序文
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・ドライアイ疾患治療の世界市場:製品別(人工涙、抗炎症薬、涙点プラグ、分泌促進物質、その他)
・ドライアイ疾患治療の世界市場:疾患別(蒸発性ドライアイ症候群、水性ドライアイ症候群)
・ドライアイ疾患治療の世界市場:流通チャンネル別(病院薬局、小売薬局、オンライン薬局)
・ドライアイ疾患治療の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Dry Eye Disease Treatment Market – Scope of the Report

TMR’s report on the global dry eye disease treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global dry eye disease treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global dry eye disease treatment market during the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, companies’ presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global dry eye disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global dry eye disease treatment market.

The report delves into the competition landscape of the global dry eye disease treatment market. Key players operating in the global dry eye disease treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global dry eye disease treatment market that have been profiled in this report.

Key Questions Answered in Dry Eye Disease Treatment Market Report

What is the scope of growth of the anti-inflammatory segment of the global dry eye disease treatment market?
What will be the Y-o-Y growth of the global dry eye disease treatment market between 2020 and 2030?
What is the influence of changing trends in cyclosporine on the global dry eye disease treatment market?
Will North America continue to be the most profitable market for dry eye disease drug providers?
Which factors are anticipated to hamper the growth of the global dry eye disease treatment market during the forecast period?
Which are the leading companies in the global dry eye disease treatment market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global dry eye disease treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global dry eye disease treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global dry eye disease treatment market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the dry eye disease treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global dry eye disease treatment market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global dry eye disease treatment market more reliably and accurately.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dry Eye Disease Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate Globally with Key Countries

5.4. Technological Advancement

5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)

6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018–2030

6.2.1. Artificial Tears

6.2.2. Anti-inflammatory

6.2.2.1. Cyclosporine

6.2.2.2. Corticosteroid

6.2.2.3. Others

6.2.3. Punctal Plugs

6.2.4. Secretagogue

6.2.5. Others

6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product

7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018–2030

7.2.1. Evaporative Dry Eye Syndrome

7.2.2. Aqueous Dry Eye Syndrome

7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease

8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018–2030

8.2.1. Hospital Pharmacies

8.2.2. Retail Pharmacies

8.2.3. Online Pharmacies

8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel

9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region

10. North America Dry Eye Disease Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

10.2.1. Artificial Tears

10.2.2. Anti-inflammatory

10.2.2.1. Cyclosporine

10.2.2.2. Corticosteroid

10.2.2.3. Others

10.2.3. Punctal Plugs

10.2.4. Secretagogue

10.2.5. Others

10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

10.3.1. Evaporative Dry Eye Syndrome

10.3.2. Aqueous Dry Eye Syndrome

10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

10.5.1. U.S.

10.5.2. Canada

10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Disease

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Dry Eye Disease Treatment Market Analysis and Forecast

11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

11.1.1. Artificial Tears

11.1.2. Anti-inflammatory

11.1.2.1. Cyclosporine

11.1.2.2. Corticosteroid

11.1.2.3. Others

11.1.3. Punctal Plugs

11.1.4. Secretagogue

11.1.5. Others

11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

11.2.1. Evaporative Dry Eye Syndrome

11.2.2. Aqueous Dry Eye Syndrome

11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

11.4.1. Germany

11.4.2. U.K.

11.4.3. France

11.4.4. Spain

11.4.5. Italy

11.4.6. Rest of Europe

11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By Disease

11.5.3. By Distribution Channel

11.5.4. By Country/Sub-region

12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast

12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

12.1.1. Artificial Tears

12.1.2. Anti-inflammatory

12.1.2.1. Cyclosporine

12.1.2.2. Corticosteroid

12.1.2.3. Others

12.1.3. Punctal Plugs

12.1.4. Secretagogue

12.1.5. Others

12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

12.2.1. Evaporative Dry Eye Syndrome

12.2.2. Aqueous Dry Eye Syndrome

12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

12.4.1. China

12.4.2. Japan

12.4.3. India

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By Disease

12.5.3. By Distribution Channel

12.5.4. By Country/Sub-region

13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast

13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

13.1.1. Artificial Tears

13.1.2. Anti-inflammatory

13.1.2.1. Cyclosporine

13.1.2.2. Corticosteroid

13.1.2.3. Others

13.1.3. Punctal Plugs

13.1.4. Secretagogue

13.1.5. Others

13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

13.2.1. Evaporative Dry Eye Syndrome

13.2.2. Aqueous Dry Eye Syndrome

13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Rest of Latin America Latin America

13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By Disease

13.5.3. By Distribution Channel

13.5.4. By Country/Sub-region

14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast

14.1.1.

14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

14.2.1. Artificial Tears

14.2.2. Anti-inflammatory

14.2.2.1. Cyclosporine

14.2.2.2. Corticosteroid

14.2.2.3. Others

14.2.3. Punctal Plugs

14.2.4. Secretagogue

14.2.5. Others

14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

14.3.1. Evaporative Dry Eye Syndrome

14.3.2. Aqueous Dry Eye Syndrome

14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Disease

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Competitive Landscape

15.1. Market Player – Competition Matrix (by Tier and Size of companies)

15.2. Market Share / Position Analysis, by Company, 2018

15.3. Competitive Business Strategies

15.4. Company Profiles

15.4.1. Novartis AG

15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.1.2. Growth Strategies

15.4.1.3. SWOT Analysis

15.4.2. Allergan

15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.2.2. Growth Strategies

15.4.2.3. SWOT Analysis

15.4.3. Santen Pharmaceutical Co., Ltd.

15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.3.2. Growth Strategies

15.4.3.3. SWOT Analysis

15.4.4. OASIS Medical

15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.4.2. Growth Strategies

15.4.4.3. SWOT Analysis

15.4.5. Sun Pharmaceutical Industries Ltd.

15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.5.2. Growth Strategies

15.4.5.3. SWOT Analysis

15.4.6. Johnson & Johnson

15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.6.2. Growth Strategies

15.4.6.3. SWOT Analysis

15.4.7. Otsuka Pharmaceutical Co., Ltd.

15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.7.2. Growth Strategies

15.4.7.3. SWOT Analysis

15.4.8. Sentiss Pharma Pvt. Ltd.

15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.8.2. Growth Strategies

15.4.8.3. SWOT Analysis

15.4.9. RegeneRx (ReGenTree, LLC)

15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.9.2. Growth Strategies

15.4.9.3. SWOT Analysis

15.4.10. Bausch Health Companies, Inc.

15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.10.2. Growth Strategies

15.4.10.3. SWOT Analysis

List of Tables

Table 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030